thalidomide has been researched along with B Virus Infection in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Excerpt | Relevance | Reference |
---|---|---|
"Multiple myeloma is the second most common hematologic malignancy, with approximately 15,000 new cases each year in the United States." | 2.41 | Recent advances in multiple myeloma. ( Berenson, JR; Sjak-Shie, NN; Vescio, RA, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Lomas, OC | 1 |
Streetly, M | 1 |
Pratt, G | 1 |
Cavet, J | 1 |
Royston, D | 1 |
Schey, S | 1 |
Ramasamy, K | 1 |
Passeron, T | 1 |
Sjak-Shie, NN | 1 |
Vescio, RA | 1 |
Berenson, JR | 1 |
2 reviews available for thalidomide and B Virus Infection
Article | Year |
---|---|
[What's new in dermatological research?].
Topics: Biomedical Research; Dermatitis, Atopic; Dermatology; Herpesviridae Infections; HIV Infections; Huma | 2010 |
Recent advances in multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Chromosome | 2000 |
1 other study available for thalidomide and B Virus Infection
Article | Year |
---|---|
The management of Castleman disease.
Topics: Adrenal Cortex Hormones; Anti-Retroviral Agents; Antibodies, Monoclonal; Antineoplastic Combined Che | 2021 |